Geographic Atrophy: Understanding New and Emerging Treatment Options for Advanced Dry AMD
Updated: Aug 31
New Developments in the Management of Geographic Atrophy
Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration (AMD) that affects the macula—the central area of the retina responsible for detailed vision.
For many years, patients diagnosed with geographic atrophy had limited treatment options beyond observation, lifestyle advice, and visual rehabilitation. However, significant advances in retinal research have transformed the way we understand and manage this condition.
Today, the focus is moving towards earlier identification of disease changes, personalised monitoring, and emerging treatments that aim to slow progression and preserve remaining vision.
What Is Geographic Atrophy?
Geographic atrophy occurs when areas of the retinal pigment epithelium (RPE), photoreceptors, and associated retinal structures gradually deteriorate. OCT scan and Fundus Autofluorescence (FAF) scans very useful tools to diagnose this condition.
As these areas enlarge, they can affect central vision and make everyday activities such as reading, recognising faces, and detailed visual tasks increasingly difficult.
The speed of progression varies greatly between individuals. This makes accurate assessment, monitoring, and personalised advice essential.
The Importance of Advanced Retinal Imaging
Understanding the pattern and activity of geographic atrophy is a key part of effective management.
Modern retinal imaging allows specialists to identify subtle changes and monitor disease progression over time.
One particularly valuable technique is fundus autofluorescence (FAF) imaging.
How Fundus Autofluorescence Helps in Geographic Atrophy
Mr. Kumar has particular expertise in the use of fundus autofluorescence imaging to assess retinal health in patients with geographic atrophy and dry AMD.
Autofluorescence imaging provides information about the health and function of the retinal pigment epithelium by highlighting areas of stress, dysfunction, and retinal change that may not always be visible with standard examination alone.
FAF can help clinicians:
· Map the extent and pattern of geographic atrophy
· Identify areas at risk of future progression
· Monitor changes over time
· Support personalised discussions about prognosis and treatment options
By combining clinical examination with advanced imaging techniques such as OCT and autofluorescence, Mr. Kumar can provide a detailed assessment of each patient’s individual retinal condition.
Current and Emerging Treatment Options for Geographic Atrophy
1. Complement Inhibitor Therapies: Targeting Disease Pathways
One of the most important developments in GA treatment has been the introduction of therapies that target the complement system, part of the immune response involved in AMD-related inflammation and retinal damage.
These treatments aim to reduce excessive complement activity and slow the expansion of geographic atrophy in selected patients.
Complement-based therapies include:
· Complement C3 inhibitors
· Complement C5 inhibitors
While these treatments represent an important advance, they do not currently restore retinal cells that have already been lost. Careful patient selection and discussion with a retinal specialist are essential.
2. Photobiomodulation: Supporting Retinal Cellular Health
Valeda® Light Therapy for Dry AMD Valeda is a light-based treatment that uses photobiomodulation and is available for selected patients with dry age-related macular degeneration (AMD).
For detailed patient information about Valeda, including how the treatment works and who may be suitable, please see the manufacturer's patient information brochure.
PBM uses specific wavelengths of light to influence cellular processes that may support:
· Mitochondrial energy production
· Reduction of oxidative stress
· Retinal pigment epithelium function
· Cellular resilience
The aim is to support the function of remaining retinal cells and improve the retinal environment.
Although research continues, photobiomodulation represents an innovative non-invasive approach being explored for suitable patients with dry AMD.
3. Supportive Care and Vision Preservation Strategies
Alongside emerging treatments, maintaining overall retinal health remains important.
Management may include:
· Regular retinal monitoring
· Healthy lifestyle choices
· Smoking cessation where relevant
· Appropriate nutritional advice
· Low vision support when required
Early recognition of visual changes and regular specialist review can help patients access appropriate care at the right time.
Can Geographic Atrophy Be Treated Successfully?
Currently, no treatment can reverse established geographic atrophy or regenerate retinal cells that have already been lost.
The goals of modern management are to:
· Slow disease progression where possible
· Preserve remaining vision
· Detect changes early
· Help patients maintain independence and quality of life
The most appropriate approach depends on the individual’s retinal findings, rate of progression, overall health, and personal priorities.
How Mr. Kumar Can Help
A diagnosis of geographic atrophy can raise many questions. Understanding the condition, available treatments, and future options is an important part of retinal care. Often patients with macular degeneration is discharged by NHS Hospitals.
Mr. Kumar combines specialist retinal expertise with advanced imaging techniques to help patients understand their condition and make informed decisions about their eye health.
He can provide guidance on:
· The stage and pattern of geographic atrophy
· Findings from OCT and auto fluorescence imaging
· Risk of progression
· Current treatment options including referral for Photobiomodulation treatment locally
· Emerging therapies and whether they may be appropriate
· Signposting patients towards the most suitable next steps in their care
If you or a family member has geographic atrophy and would like more information, Mr. Kumar can answer your questions and help guide you in the right direction.
The Future of Geographic Atrophy Care
Research into geographic atrophy is advancing rapidly. With improvements in retinal imaging, complement-based treatments, photobiomodulation, and other emerging therapies, the future of dry AMD management is becoming increasingly personalised.
For patients, expert assessment and clear guidance are essential to understanding what options are available today and what developments may become available in the future.
Conclusion
Geographic atrophy remains a complex retinal condition, but advances in diagnosis and treatment are creating new opportunities for patients.
Through detailed assessment, advanced imaging—including fundus autofluorescence—and discussion of current and emerging therapies, Mr. Kumar can help patients navigate their options and receive the most appropriate advice for their individual retinal health.
Comments